Publicacións nas que colabora con Hortensia Álvarez Díaz (10)

2024

  1. Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

    Frontiers in Immunology, Vol. 15

2023

  1. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

2022

  1. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

    The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049

2021

  1. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

  2. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 11, pp. 2121-2126

  3. Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide

    Infection, Vol. 47, Núm. 1, pp. 115-119

2018

  1. Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges

    International Journal of STD and AIDS, Vol. 29, Núm. 9, pp. 933-936

  2. Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies

    Journal of Medical Virology, Vol. 90, Núm. 6, pp. 1094-1098

2016

  1. Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers

    AIDS, Vol. 30, Núm. 16, pp. 2561-2563